Retrospective and prospective international EKoSoNic registry of the treatment and Clinical Outcomes of patients with Pulmonary Embolism
This study is for people between the age of 18 and 80 who are being treated for lung artery clots with clot-dissolving drugs and a commercially available device called the EkoSonic Endovascular System (EKOS). The EKOS uses ultrasound energy to make it easier for the drug to enter the clot, which may reduce treatment time, and the amount of drug needed to dissolve the clot. This study is to gather data into a clinical registry to better understand length of treatment, amount of drug use and how health and quality of life are impacted over time by treatment.
Available at the following location(s)
Do you need help with some of the labels on this page?
Read our glossary of terms